Search Results - "MODIANO, M"

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer by Chen, H, Modiano, M R, Neal, J W, Brahmer, J R, Rigas, J R, Jotte, R M, Leighl, N B, Riess, J W, Kuo, C J, Liu, L, Gao, B, DiCioccio, A T, Adjei, A A, Wakelee, H A

“…Background: This study evaluated the efficacy and safety of ziv-aflibercept in combination with cisplatin and pemetrexed in non-small cell lung cancer (NSCLC)…”
Get full text

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial by Burris, 3rd, H A, Moore, M J, Andersen, J, Green, M R, Rothenberg, M L, Modiano, M R, Cripps, M C, Portenoy, R K, Storniolo, A M, Tarassoff, P, Nelson, R, Dorr, F A, Stephens, C D, Von Hoff, D D

“…Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor-related symptoms. To date, no treatment has…”
Get more information

An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma by Abou-Alfa, G.K, Yoon, J.H, Modiano, M, Ryoo, B.Y, Yau, T, Freilich, B, Knox, J, Ly, M, Ahmad, H, Gahir, S, Niforos, D, Kowalski, M, Kelley, R.K

“…An abstract of a study by Abou-Alfa et al on IV TKM-080301 is subjects with advanced hepatocellular carcinoma (HCC) is presented. Subjects of the study had…”
Get full text

A phase I II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed refractory aggressive non-Hodgkin's lymphoma by Lim, Soon-Thye, Fayad, L., Tulpule, A., Modiano, M., Cabanillas, F., Laffranchi, B., Allievi, C., Bernareggi, A., Levine, Alexandra M.

“…The purpose of the study was to evaluate the safety, efficacy, and pharmacokinetics of pixantrone (BBR2778) when substituted for etoposide in the ESHAP regimen…”
Get full text

Linguistic imperialism, cultural integrity, and EIL by Modiano, Marko

“…Those who view the spread of English as linguistic imperialism question the English language teaching and learning enterprise because, from their point of…”
Get full text

ZD0473 treatment in lung cancer: an overview of the clinical trial results by Treat, J, Schiller, J, Quoix, E, Mauer, A, Edelman, M, Modiano, M, Bonomi, P, Ramlau, R, Lemarie, E

“…Three open-label, non-comparative, multicentre Phase II trials have examined the efficacy and tolerability of ZD0473 as first- and second-line therapy in…”
Get full text

An Educational Program to Increase Cervical and Breast Cancer Screening in Hispanic Women: A Southwest Oncology Group Study by Hansen, Lisa K, Feigl, Polly, Modiano, Manuel R, Lopez, Jose A, Escobedo Sluder, Sylvia, Moinpour, Carol M, Pauler, Donna K, Meyskens, Frank L

“…We conducted a community-based pilot study to train Hispanic cancer survivors as promotoras (lay health educators) to encourage their social contacts to obtain…”
Get full text

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer by BLANKE, C. D, SHULTZ, J, CARLIN, D, HAMMERSHAIMB, L, HALLER, D, COX, J, MODIANO, M, ISAACS, R, KASIMIS, B, SCHILSKY, R, FLEAGLE, J, MOORE, M, KEMENY, N

“…Trimetrexate (TMTX) biochemically modulates 5-fluorouracil (5-FU) and leucovorin (LCV). Two phase II trials demonstrated promising activity for TMTX/5-FU/LCV…”
Get full text

Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229 by Modiano, M R, Villar-Werstler, P, Crowley, J, Salmon, S E

“…The objective of this investigation was to assess the impact of race (black v white) on the survival of patients with multiple myeloma treated within the…”
Get more information

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial by Mackey, John R, Prof, Martin, Miguel, Prof, Pienkowski, Tadeusz, Prof, Rolski, Janusz, MD, Guastalla, Jean-Paul, MD, Sami, Amer, MD, Glaspy, John, MD, Juhos, Eva, MD, Wardley, Andrew, MD, Fornander, Tommy, MD, Hainsworth, John, MD, Coleman, Robert, MD, Modiano, Manuel R, MD, Vinholes, Jeferson, MD, Pinter, Tamas, MD, Rodríguez-Lescure, Álvaro, MD, Colwell, Bruce, MD, Whitlock, Pierre, MD, Provencher, Louise, MD, Laing, Kara, MD, Walde, David, MD, Price, Chris, MD, Hugh, Judith C, MD, Childs, Barrett H, MD, Bassi, Kimberly, BS, Lindsay, Mary-Ann, PharmD, Wilson, Véronique, MSc, Rupin, Matthieu, MSc, Houé, Vincent, MSc, Vogel, Charles, MD

“…Summary Background We compared standard adjuvant anthracycline chemotherapy with anthracycline–taxane combination chemotherapy in women with operable…”
Get full text

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial by Burris, 3rd, H A, Moore, M J, Andersen, J, Green, M R, Rothenberg, M L, Modiano, M R, Cripps, M C, Portenoy, R K, Storniolo, A M, Tarassoff, P, Nelson, R, Dorr, F A, Stephens, C D, Von Hoff, D D

“…Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor-related symptoms. To date, no treatment has…”
Get full text

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study by von der Maase, H, Hansen, S W, Roberts, J T, Dogliotti, L, Oliver, T, Moore, M J, Bodrogi, I, Albers, P, Knuth, A, Lippert, C M, Kerbrat, P, Sanchez Rovira, P, Wersall, P, Cleall, S P, Roychowdhury, D F, Tomlin, I, Visseren-Grul, C M, Conte, P F

“…Gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) were compared in patients with locally advanced or metastatic…”
Get full text

Adjuvant Docetaxel for Node-Positive Breast Cancer by Martin, Miguel, Pienkowski, Tadeusz, Mackey, John, Pawlicki, Marek, Guastalla, Jean-Paul, Weaver, Charles, Tomiak, Eva, Al-Tweigeri, Taher, Chap, Linnea, Juhos, Eva, Guevin, Raymond, Howell, Anthony, Fornander, Tommy, Hainsworth, John, Coleman, Robert, Vinholes, Jeferson, Modiano, Manuel, Pinter, Tamas, Tang, Shou C, Colwell, Bruce, Prady, Catherine, Provencher, Louise, Walde, David, Rodriguez-Lescure, Alvaro, Hugh, Judith, Loret, Camille, Rupin, Matthieu, Blitz, Sandra, Jacobs, Philip, Murawsky, Michael, Riva, Alessandro, Vogel, Charles

“…This randomized trial included almost 1500 women with breast cancer and positive axillary nodes and compared treatment with doxorubicin and cyclophosphamide…”
Get full text

Quality of life (QoL) in elderly NSCLC patients (pts) treated with nab-paclitaxel/carboplatin (nab-P/C) in the ABOUND.70+ trial by Langer, C.J., Anderson, E., Jotte, R., Goldman, J., Haggstrom, D., Modiano, M., Socoteanu, M., Smith, D., Dahkil, C., Konduri, K., Kim, E., Sanford, A., Amiri, K., Weiss, J.

Get full text

Mitoxantrone and Fludarabine in the Treatment of Patients with Non-Hodgkin's Lymphoma Failing Primary Therapy with a Doxorubicin-or Mitoxantrone-Containing Regimen by Gregory, Stephanie A., Vose, Julie, Modiano, Manuel, Kraemer, Kenneth, Rifkin, Robert, Rubin, Abbe, Menduni, Thomas, Ghalie, Richard

“…Patients with recurrent lymphoma of any grade were treated with mitoxantrone (12 mg/m2 given intravenously (IV) over 15-30 minutes on day 1) followed by…”
Get full text

Abstract P6-13-21: Phase 1 study of GR antagonist mifepristone (M) in combination with eribulin (E) in advanced solid tumors, with dose expansion in patients (pts) with GR-positive triple-negative breast cancer (TNBC) by Wilks, S, Modiano, M, Spira, A, Becerra, C, Walling, J, Nguyen, D, Baker, G, Conzen, SD, Nanda, R

“…Abstract Background: High tumor GR expression is associated with poor prognosis in estrogen receptor (ER) negative early-stage breast cancer. Co-treatment with…”
Get full text

46 - An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma by Abou-Alfa, G.K., Yoon, J.H., Modiano, M., Ryoo, B.Y., Yau, T., Freilich, B., Knox, J., Ly, M., Ahmad, H., Gahir, S., Niforos, D., Kowalski, M., Kelley, R.K.

Get full text

Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer by Berry, William, Dakhil, Shaker, Modiano, Manuel, Gregurich, Maryann, Asmar, Lina

“…We compared median time to treatment failure of men with asymptomatic, hormone refractory, progressive prostate cancer treated with mitoxantrone plus…”
Get more information

Quality of life (QoL) in elderly patients (pts) with advanced NSCLC treated with nab-paclitaxel (nab-P) + carboplatin (C): Interim results from the ABOUND.70+ study by Weiss, J., Kim, E., Amiri, K.I., Anderson, E., Dakhil, S., Haggstrom, D., Jotte, R., Konduri, K., Modiano, M., Ong, T.J., Sanford, A., Smith, D., Socoteanu, M., Goldman, J., Langer, C.

Get full text

Cancer in Hispanics: issues of concern by Modiano, M R, Villar-Werstler, P, Meister, J, Figueroa-Vallés, N

“…Hispanics are among the fastest growing minorities in the United States, after Asian-Americans and Pacific-Islanders. Hispanics, Latinos, Chicanos,…”
Get more information